Wendall Wierenga, Director at ONYX PHARMACEUTICALS INC (ONXX), sold 5,000 shares at $40.98 ($205K) on 2008-08-27, disclosed to the SEC on 2008-08-27.
Open-market sale of $205k ONXX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.98 | 2,000 | $82K | 40.0% |
| 2 | $41.00 | 1,500 | $62K | 30.0% |
| 3 | $41.04 | 1,500 | $62K | 30.0% |
| Total | $41.00 avg | 5,000 | $205K | 100% |
| Filing → |
| CYTK | SELL | 2024-11-26 | $37K | — | Filing → |
| CYTK | SELL | 2024-10-31 | $233K | — | Filing → |
| CYTK | SELL | 2023-12-27 | $368K | — | Filing → |